Angiocidin promotes pro-inflammatory cytokine production and antigen presentation in multiple sclerosis

Aida, 1990, Removal of endotoxin from protein solutions by phase separation using Triton X-114, J. Immunol. Methods, 132, 191, 10.1016/0022-1759(90)90029-U Armitage, 1990, Regulation of human T cell proliferation by IL-7, J. Immunol., 144, 938, 10.4049/jimmunol.144.3.938 Balkwill, 2004, Cancer and the chemokine network, Nat. Rev. Cancer, 4, 540, 10.1038/nrc1388 Benveniste, 1997, Role of macrophages/microglia in multiple sclerosis and experimental allergic encephalomyelitis, J. Mol. Med., 75, 165, 10.1007/s001090050101 Bielekova, 1999, Preferential expansion of autoreactive T lymphocytes from the memory T-cell pool by IL-7, J. of Neuroimmunol., 100, 115, 10.1016/S0165-5728(99)00200-3 Bruck, 2005, The pathology of multiple sclerosis is the result of focal inflammatory demyelination with axonal damage, J. Neurol., 252, 3, 10.1007/s00415-005-5002-7 Bruck, 2005, Inflammatory demyelination is not central to the pathogenesis of multiple sclerosis, J. Neurol., 252, 10, 10.1007/s00415-005-5003-6 Chapoval, 1998, CSF-1 (M-CSF) differentially sensitizes mononuclear phagocyte subpopulations to endotoxin in vivo: a potential pathway that regulates the severity of gram-negative infections, J. Leukoc. Biol., 63, 245, 10.1002/jlb.63.2.245 Cuschieri, 2004, Implications of proteasome inhibition: an enhanced macrophage phenotype, Cell. Immunol., 227, 140, 10.1016/j.cellimm.2004.03.005 Davidson, 2004, Antisecretory factor expression is regulated by inflammatory mediators and influences the severity of experimental autoimmune encephalomyelitis, J. Leukoc. Biol., 76, 835, 10.1189/jlb.0204085 Davidson, 2004, Distribution and immunoregulatory properties of antisecretory factor, Lab. Invest., 84, 307, 10.1038/labinvest.3700036 Deveraux, 1995, Molecular cloning and expression of a 26 S protease subunit enriched in dileucine repeats, J. Biol. Chem., 270, 23726, 10.1074/jbc.270.40.23726 Dimitrov, 2005, The endothelial apoptotic activity of angiocidin is dependent on its polyubiquitin binding activity, Br. J. Cancer., 93, 662, 10.1038/sj.bjc.6602773 Hernández-Caselles, 1995, Interleukin-7 rescues human activated T lymphocytes from apoptosis induced by glucocorticoesteroids and regulates bcl-2 and CD25 expression, Hum. Immunol., 43, 181, 10.1016/0198-8859(94)00168-P Jennische, 2006, Immunohistochemical staining patterns using epitope-specific antibodies indicate conformation variants of antisecretory factor/S5a in the CNS, APMIS, 114, 529, 10.1111/j.1600-0463.2006.apm_464.x Johansson, 1995, Molecular cloning and expression of a pituitary gland protein modulating intestinal fluid secretion, J. Biol. Chem., 270, 20615, 10.1074/jbc.270.35.20615 Kremlev, 1998, CSF-1 (M-CSF) enhances the inflammatory response of fibronectin-primed macrophages: pathways involved in activation of the cytokine network, Nat. Immun., 16, 228, 10.1159/000069449 Kremlev, 1998, Cytokine release by macrophages after interacting with CSF-1 and extracellular matrix proteins: characteristics of a mouse model of inflammatory responses in vitro, Cell. Immunol., 185, 59, 10.1006/cimm.1998.1276 Londei, 1990, Interleukin 7 is a growth factor for mature human T cells, Eur. J. Immunol., 20, 425, 10.1002/eji.1830200228 Lynch, 1994, Interleukin 7 promotes long-term in vitro growth of antitumor cytotoxic T lymphocytes with immunotherapeutic efficacy in vivo, J. Exp. Med., 179, 31, 10.1084/jem.179.1.31 Muller, 2004, Chemokines and chemokine receptors: potential therapeutic targets in multiple sclerosis, Curr. Drug. Targets Inflamm. Allergy, 3, 279, 10.2174/1568010043343732 McCarthy, 1980, Preparation of separate astroglial and oligodendroglial cell cultures from rat cerebral tissue, J. Cell. Biol., 85, 890, 10.1083/jcb.85.3.890 Nilsson, 1992, Induction of anti-secretory factor in mice by the nonintestinal parasite Schistosoma mansoni, J. Parasitol., 78, 1055, 10.2307/3283229 Poon, 2004, Clinical significance of thrombospondin 1 expression in hepatocellular carcinoma, Clin. Cancer. Res., 12, 4150, 10.1158/1078-0432.CCR-03-0435 Raivich, 2004, Brain microglia and blood-derived macrophages: molecular profiles and functional roles in multiple sclerosis and animal models of autoimmune demyelinating disease, Brain Res. Brain Res. Rev., 46, 261, 10.1016/j.brainresrev.2004.06.006 Sabherwal, 2006, Integrin alpha2beta1 mediates the anti-angiogenic and anti-tumor activities of angiocidin, a novel tumor-associated protein, Exp. Cell. Res., 312, 2443, 10.1016/j.yexcr.2006.04.009 Sabherwal, 2007, Clinical significance of serum angiocidin levels in hepatocellular carcinoma, Cancer Lett., 251, 28, 10.1016/j.canlet.2006.10.023 Tuszynski, 1993, Identification and characterization of a tumor cell receptor for CSVTCG, a thrombospondin adhesive domain, J. Cell. Biol., 120, 513, 10.1083/jcb.120.2.513 Vella, 1998, Cytokine-induced survival of activated T cells in vitro and in vivo, Proc. Natl. Acad. Sci. U. S. A., 95, 3810, 10.1073/pnas.95.7.3810 Wakiyama, 2001, The localization of thrombospondin-1 (TSP-1), cysteine-serine-valine-threonine-cysteine-glycine (CSVTCG) TSP receptor, and matrix metalloproteinase-9 (MMP-9) in colorectal cancer, Histol. Histopathol., 16, 345 Young, 1998, Characterization of two polyubiquitin binding sites in the 26 S protease subunit 5a, J. Biol. Chem., 273, 5461, 10.1074/jbc.273.10.5461 Zhou, 2004, Cloning and characterization of angiocidin, a tumor cell binding protein for thrombospondin-1, J. Cell. Biochem., 92, 125, 10.1002/jcb.20076